Neurovascular Intervention Devices Global Market – Forecast to 2024 - Product Image

Neurovascular Intervention Devices Global Market – Forecast to 2024

  • ID: 4538815
  • Report
  • Region: Global
  • 391 Pages
  • IQ4I Research & Consultancy Pvt. Ltd
1 of 5
The Neurovascular Intervention Devices Global Market is Expected to Grow at a High Single Digit CAGR to Reach $4,473.2 Million by 2024

FEATURED COMPANIES

  • Asahi Intecc Co., Ltd.
  • Cardiatis
  • Evasc Medical Systems
  • Medtronic Plc
  • Penumbra Inc
  • Rapid Medical
  • MORE

Neurovascular Intervention devices are used treat intracranial aneurysm, ischemic stroke, arteriovenous malformation, carotid stenosis and other diseases like intracranial stenosis, dural fistula, etc. According to this analysis, the Neurovascular Intervention devices global market is expected to grow at a high single digit CAGR to reach $4,473.2 million by 2024. The increase in incidence and prevalence of neurovascular diseases like intracranial aneurysm, stroke and arteriovenous malformations, increase in aging population, technological advancement, acquisitions and favourable reimbursements are increasing the use of artificial embolization devices, stents, thromobectomy devices and support devices which include microcatheters, embolic protection system and others as an efficient way for treating the neurovascular diseases.

Neurovascular Intervention devices global market is segmented on the basis of products, applications and geography. The products are segmented into artificial embolization devices, stents, thrombectomy devices and support devices. The artificial embolization devices segment accounted the largest share in 2017 and is projected to grow at mid single digit CAGR from 2017 to 2024 due to technological advancements in coils & flow diverter, development of coils for dual application i.e. for intracranial aneurysm and arteriovenous malformation.

The artificial embolization devices are sub-segment into coils, liquid embolics, flow diverter and flow disruptor. The coil segment accounted the largest share in 2017 due to development of softest coils and more number of companies producing bare metal coils over coated coils due to its advantages. The liquid embolics segment is fastest growing segment and is projected to grow at a strong CAGR of 8.7% from 2017 to 2024 due to its advantages like presence of effective embolic materials which penetrates small vessels, cohesiveness and non-adherence when compared to glues. The coils are further classified into bare metal coils and coated coils. The bare metal coil segment accounted for the largest share in 2017 and fastest growing segment and is projected to grow at a CAGR of 6.4% from 2017 to 2024 due to increased compatibility, efficacy and cost efficient. The Stents are sub-segmented into intracranial stents and carotid stents. The carotid stents segment accounted the largest share of 74.2% and fastest growing segment in 2017 due to development of self expanding stents. The intracranial stents are sub-segmented into stenosis stent, aneurysm coil stent, neck reconstruction stent and stent graft. The aneurysm coil stents segment accounted the largest share in 2017 and fastest growing segment during forecasting period due to increase intracranial aneurysm procedures. The thrombectomy devices are sub-segmented into stent retrievers and aspiration devices. The stent retriever segment accounted the largest share of 76.3% and fastest growing segment from 2017 to 2024 due to product approvals and expansion in indication of treatment from 6 hrs to 24 hrs. The Support devices are sub-segmented into microcatheters, embolic protection system and others. The microcatheter segment accounted the largest share in 2017.

The applications are segmented into intracranial aneurysm, ischemic stroke, arteriovenous malformation and carotid stenosis & others. Among application, intracranial aneurysm segment accounted for the largest share in 2017 due to the increase in incidence and prevalence of intracranial aneurysm and increase in aging population. The Ischemic stroke segment is fastest growing segment during forecasting period due to increase in product regulatory approvals of thrombectomy devices, increase in ischemic stroke patients and procedures, technological advancement in stent retriever and aspiration devices.

Geography is segmented as North America (U.S. and others), Europe (Germany, U.K., France and Others), Asia-Pacific (Japan, China, India, and Others) and Rest of the World (Brazil, Rest of Latin America and Middle East & others). North America accounts for the highest market share followed by Europe. Favourable reimbursement coverage and increase in incidence and prevalence of neurovascular diseases are the driving factors of Neurovascular Intervention devices market. However, Asian countries especially India and China are the fastest growing nations at strong CAGR of 11.4% from 2017 to 2024 with its growing demand for neurovascular intervention device due to increase in aging population and decreasing the cost of neurovascular products.

The Neurovascular Intervention devices market is a consolidated, highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the key players of the Neurovascular Intervention device are Stryker Corporation (U.S.), Medtronic Plc (Ireland), Terumo Corporation (Japan), Balt Extrusion (Blockade Medical, LLC) (France), Penumbra, Inc. (U.S.), Johnson & Johnson (U.S.), Acandis GmbH (Germany), Microport Scientific Corporation (China), Phenox GmbH (Germany), Penumbra Inc (U.S.), Abbott Laboratories (U.S.), InspireMD (Israel), Boston Scientific Corporation (U.S.) and Cardinal Health (Cordis Corporation) (U.S.).

The report provides an in-depth market analysis of the above-mentioned segments across the following regions:

North America
U.S.
Others

Europe
Germany
U.K.
France
Others

Asia-Pacific
Japan
China
India
Others

Rest of the World (RoW)
Brazil
Rest of Latin America
Middle East & Others

READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Asahi Intecc Co., Ltd.
  • Cardiatis
  • Evasc Medical Systems
  • Medtronic Plc
  • Penumbra Inc
  • Rapid Medical
  • MORE

1 Executive Summary   

2 Introduction   
2.1 Key Takeaways   
2.2 Report Scope   
2.3 Report Description   
2.4 Markets Covered   
2.5 Stakeholders   
2.6 Research Methodology   
2.6.1 Market Size Estimation   
2.6.2 Market Breakdown And Data Triangulation   
2.6.3 Secondary Sources   
2.6.4 Primary Sources   
2.6.5 Key Data Points From Secondary Sources   
2.6.6 Key Data Points From Primary Sources   
2.6.7 Assumptions   

3 Market Analysis   
3.1 Introduction   
3.2 Market Segmentation   
3.3 Factors Influencing Market   
3.3.1 Drivers And Opportunities   
3.3.1.1 Increase In Incidence And Prevalence Of Neurovascular Diseases   
3.3.1.2 Increase In Ageing Population   
3.3.1.3 Technological Advancements In Minimally Invasive Products   
3.3.1.4 Favorable Reimbursement Policies   
3.3.1.5 Acquisitions   
3.3.2 Restraints And Threats   
3.3.2.1 Adverse Events And Complications With The Implantations Of Neurovascular Intervention Devices   
3.3.2.2 Lack Of Skilled And Trained Professionals   
3.3.2.3 Product Recalls   
3.3.2.4 Stringent Regulatory Polices   
3.3.2.5 Availability Of Alternative Products   
3.4 Regulatory Affairs   
3.4.1 International Organization For Standardization   
3.4.1.1 ISO 9001: 2015 Quality Management System   
3.4.1.2 ISO 13485 Medical Devices   
3.4.1.3 ISO 10993 Biological Evaluation Of Medical Devices   
3.4.2 U.S.   
3.4.3 Canada   
3.4.4 Europe   
3.4.5 Japan   
3.4.6 China   
3.4.7 India   
3.5 Reimbursement Scenario   
3.5.1 Reimbursement Table   
3.6 Clinical Trials   
3.7 Patent Trends   
3.8 Technological Advancements   
3.8.1 Introduction   
3.8.2 Integrated Balloon System   
3.8.3 Soft Coil Technology   
3.8.4 Adujstable Clot Retreiver   
3.8.5 Advancements In Flow Diverter   
3.9 Product Approvals   
3.10 Porter’s Five Force Analysis   
3.10.1 Threat Of New Entrants   
3.10.2 Threat Of Substitutes   
3.10.3 Rivalry Among Existing Competitors   
3.10.4 Bargaining Power Of Suppliers   
3.10.5 Bargaining Power Of Buyers   
3.11 Supply Chain Analysis   
3.12 Market Share Analysis By Major Players   
3.12.1 Neurovascular Intervention Devices Global Market Share Analysis   
3.12.2 Coils Global Market Share Analysis   
3.12.3 Flow Diverters Global Market Share Analysis   
3.12.4 Intracranial Stent Global Market Share Analysis   
3.12.5 Carotid Stent Global Market Share Analysis   
3.12.6 Stent Retriever Global Market Share Analysis   
3.13 Neurovascular Intervention Devices Number Of Units By Region   
3.13.1 Coils Number Of Units By Region   
3.13.2 Liquid Embolics Number Of Units By Region   
3.13.3 Stent Retriever Number Of Units By Region   
3.13.4 Carotid Stent Number Of Units By Region   
3.14 Neurovascular Intervention Devices Company Comparison Table By Classification, Products And Applications   
3.15 Market Penetration Of Neurovascular Intervention Device Market   

4 Neurovascular Intervention Devices Global Market, By Product   
4.1 Introduction   
4.2 Artificial Embolization Devices   
4.2.1 Coils   
4.2.1.1 Bare Metal Coils   
4.2.1.2 Coated Coils   
4.2.2 Liquid Embolics   
4.2.3 Flow Diverters   
4.2.4 Flow Disruptor   
4.3 Stents   
4.3.1 Intracranial Stents   
4.3.1.1 Stenosis Stents   
4.3.1.2 Aneurysm Coil Stents   
4.3.1.3 Neck Reconstruction Stents   
4.3.1.4 Stent Graft   
4.3.2 Carotid Stents   
4.4 Thrombectomy Devices   
4.4.1 Stent Retrievers   
4.4.2 Aspiration Devices   
4.5 Support Devices   
4.5.1 Microcatheters   
4.5.2 Embolic Protection System   
4.5.3 Others   

5 Neurovascular Intervention Devices Global Market, By Application   
5.1 Introduction   
5.2 Intracranial Aneurysm   
5.3 Ischemic Stroke   
5.4 Arteriovenous Malformation   
5.5 Carotid Stenosis And Others   

6 Regional Analysis   
6.1 Introduction   
6.2 North America   
6.2.1 U.S.   
6.2.2 Others   
6.3 Europe   
6.3.1 Germany   
6.3.2 U.K.   
6.3.3 France   
6.3.4 Others   
6.4 Apac   
6.4.1 Japan   
6.4.2 China   
6.4.3 India   
6.4.4 Others   
6.5 RoW   
6.5.1 Brazil   
6.5.2 Rest Of Latin America   
6.5.3 Middle East And Others   

7 Competitive Landscape   
7.1 Introduction   
7.2 Agreement   
7.3 Approvals   
7.4 Acquisitions   
7.5 New Product Launch   
7.6 Other Developments   

8 Major Companies   
8.1 Abbott Laboratories   
8.1.1 Overview   
8.1.2 Financials   
8.1.3 Product Portfolio   
8.1.4 Key Developments   
8.1.5 Business Strategy   
8.1.6 Swot Analysis   
8.2 Acandis Gmbh   
8.2.1 Overview   
8.2.2 Financials   
8.2.3 Product Portfolio   
8.2.4 Key Developments   
8.2.5 Business Strategy   
8.2.6 Swot Analysis   
8.3 Balt Extrusion   
8.3.1 Overview   
8.3.2 Financials   
8.3.3 Product Portfolio   
8.3.4 Key Developments   
8.3.5 Business Strategy   
8.3.6 Swot Analysis   
8.4 Boston Scientific Corporation   
8.4.1 Overview   
8.4.2 Financials   
8.4.3 Product Portfolio   
8.4.4 Key Developments   
8.4.5 Business Strategy   
8.4.6 Swot Analysis   
8.5 Cardinal Health Inc. (Cordis Corporation)   
8.5.1 Overview   
8.5.2 Financials   
8.5.3 Product Portfolio   
8.5.4 Key Developments   
8.5.5 Business Strategy   
8.5.6 Swot Analysis   
8.6 Inspiremd, Inc.   
8.6.1 Overview   
8.6.2 Financials   
8.6.3 Product Portfolio   
8.6.4 Key Developments   
8.6.5 Business Strategy   
8.6.6 Swot Analysis   
8.7 Johnson & Johnson   
8.7.1 Overview   
8.7.2 Financials   
8.7.3 Product Portfolio   
8.7.4 Key Developments   
8.7.5 Business Strategy   
8.7.6 Swot Analysis   
8.8 Medtronic, Plc   
8.8.1 Overview   
8.8.2 Financials   
8.8.3 Product Portfolio   
8.8.4 Key Developments   
8.8.5 Business Strategy   
8.8.6 Swot Analysis   
8.9 Microport Scientific Corporation   
8.9.1 Overview   
8.9.2 Financials   
8.9.3 Product Portfolio   
8.9.4 Key Developments   
8.9.5 Business Strategy   
8.9.6 Swot Analysis   
8.10 Penumbra, Inc   
8.10.1 Overview   
8.10.2 Financials   
8.10.3 Product Portfolio   
8.10.4 Key Developments   
8.10.5 Business Strategy   
8.10.6 Swot Analysis   
8.11 Phenox Gmbh   
8.11.1 Overview   
8.11.2 Financials   
8.11.3 Product Portfolio   
8.11.4 Key Developments   
8.11.5 Business Strategy   
8.11.6 Swot Analysis   
8.12 Stryker Corporation   
8.12.1 Overview   
8.12.2 Financials   
8.12.3 Product Portfolio   
8.12.4 Key Developments   
8.12.5 Business Strategy   
8.12.6 Swot Analysis   
8.13 Terumo Corporation   
8.13.1 Overview   
8.13.2 Financials   
8.13.3 Product Portfolio   
8.13.4 Key Developments   
8.13.5 Business Strategy   
8.13.6 Swot Analysis   

List Of Tables
Table 1 Neurovascular Intervention Devices Global Market Revenue, By Region, (2016-2024) ($Mn)   
Table 2 Coils Number Of Units, By Region, (2016-2024) (No’s)   
Table 3 Liquid Embolics Number Of Units, By Region, (2016-2024) (No’s)   
Table 4 Stent Retriever Number Of Units, By Region, (2016-2024) (No’s)   
Table 5 Carotid Stent Number Of Units, By Region,(2016-2024) (No’s)   
Table 6 Neurovascular Intervention Devices Global Market Revenue, By Product, (2016-2024) ($Mn)   
Table 7 Artificial Embolization Devices Global Market Revenue, By Product Type, (2016-2024) ($Mn) 
Table 8 Artificial Embolization Devices Global Market Revenue, By Region, (2016-2024) ($Mn)     
Table 9 Coils Global Market Revenue, By Product Type, (2016-2024) ($Mn)   
Table 10 Coils Global Market Revenue, By Region, (2016-2024) ($Mn)           
Table 11 Bare Metal Coils Global Market Revenue, By Region, (2016-2024) ($Mn)     
Table 12 Coated Coils Global Market Revenue, By Region, (2016-2024) ($Mn)          
Table 13 Liquid Embolics Global Market Revenue, By Region, (2016-2024) ($Mn)           
Table 14 Flow Diverters Global Market Revenue, By Region, (2016-2024) ($Mn)   
Table 15 Flow Disruptor Global Market Revenue, By Region, (2016-2024) ($Mn)   
Table 16 Stents Global Market Revenue, By Product Type, (2016-2024) ($Mn)   
Table 17 Stents Global Market Revenue, By Region, (2016-2024) ($Mn)   
Table 18 Intracranial Stents Global Market Revenue, By Product Type, (2016-2024) ($Mn)                              
Table 19 Intracranial Stents Global Market Revenue, By Region, (2016-2024) ($Mn)          
Table 20 Stenosis Stents Global Market Revenue, By Region, (2016-2024) ($Mn)          
Table 21 Aneurysm Coil Stents Global Market Revenue, By Region, (2016-2024) ($Mn)              
Table 22 Neck Reconstruction Stents Global Market Revenue, By Region, (2016-2024) ($Mn)           
Table 23 Stent Graft Global Market Revenue, By Region, (2016-2024) ($Mn)          
Table 24 Carotid Stents Global Market Revenue, By Region, (2016-2024) ($Mn)           
Table 25 Thrombectomy Devices Global Market Revenue, By Product Type, (2016-2024) ($Mn)   
Table 26 Thrombectomy Devices Global Market Revenue, By Region, (2016-2024) ($Mn)   
Table 27 Stent Retrievers Global Market Revenue, By Region, (2016-2024) ($Mn)            
Table 28 Aspiration Devices Global Market Revenue, By Region, (2016-2024) ($Mn)           
Table 29 Support Devices Global Market Revenue, By Product Type, (2016-2024) ($Mn)   
Table 30 Support Devices Global Market Revenue, By Region, (2016-2024) ($Mn)   
Table 31 Microcatheters Global Market Revenue, By Region, (2016-2024) ($Mn)            
Table 32 Embolic Protection System Global Market Revenue, By Region, (2016-2024) ($Mn)            
Table 33 Others Global Market Revenue, By Region, (2016-2024) ($Mn)   
Table 34 Neurovascular Intervention Devices Global Market Revenue, By Application, (2016-2024) ($Mn)   
Table 35 Intracranial Aneurysm Global Market Revenue, By Region, (2016-2024) ($Mn)          
Table 36 Ischemic Stroke Global Market Revenue, By Region, (2016-2024) ($Mn)             
Table 37 Arteriovenous Malformation Global Market Revenue, By Region, (2016-2024) ($Mn)   
Table 38 Carotid Stenosis & Others Global Market Revenue, By Region, (2016-2024) ($Mn)           
Table 39 Neurovascular Intervention Devices Global Market Revenue, By Region, (2016-2024) ($Mn)   
Table 40 North America Neurovascular Intervention Devices Market Revenue, By Product, (2016-2024) ($Mn)   
Table 41 North America Artificial Embolization Device Market, By Product Type, (2016-2024) ($Mn)          
Table 42 North America Coils Market Revenue, By Product Type, (2016-2024) ($Mn)   
Table 43 North America Stents Market Revenue, By Product Type, (2016-2024) ($Mn)   
Table 44 North America Intracranial Stents Market Revenue, By Product Type, (2016-2024) ($Mn)            
Table 45 North America Thrombectomy Device Market Revenue, By Product Type, (2016-2024) ($Mn)               
Table 46 North America Support Devices Market Revenue, By Product Type, (2016-2024) ($Mn)   
Table 47 North America Neurovascular Intervention Devices Market Revenue, By Application, (2016-2024) ($Mn)   
Table 48 North America Neurovascular Intervention Devices Market Revenue, By Country, (2016-2024) ($Mn)   
Table 49 Europe Neurovascular Intervention Devices Market Revenue, By Product, (2016-2024) ($Mn)
Table 50 Europe Artificial Embolization Device Market, By Product Type, (2016-2024) ($Mn)                        
Table 51 Europe Coils Market Revenue, By Product Type, (2016-2024) ($Mn)   
Table 52 Europe Stents Market Revenue, By Product Type, (2016-2024) ($Mn)   
Table 53 Europe Intracranial Stents Market Revenue, By Product Type, (2016-2024) ($Mn)   
Table 54 Europe Thrombectomy Device Market Revenue, By Product Type, (2016-2024) ($Mn)   
Table 55 Europe Support Devices Market Revenue, By Product Type, (2016-2024) ($Mn)   
Table 56 Europe Neurovascular Intervention Devices Market Revenue, By Application, (2016-2024) ($Mn)   
Table 57 Europe Neurovascular Intervention Devices Market Revenue, By Country, (2016-2024) ($Mn)   
Table 58 Apac Neurovascular Intervention Devices Market Revenue, By Product, (2016-2024) ($Mn)   
Table 59 Apac Artificial Embolization Device Market, By Product Type, (2016-2024) ($Mn)   
Table 60 Apac Coils Market Revenue, By Product Type, (2016-2024) ($Mn)   
Table 61 Apac Stents Market Revenue, By Product Type, (2016-2024) ($Mn)   
Table 62 Apac Intracranial Stents Market Revenue, By Product Type, (2016-2024) ($Mn)   
Table 63 Apac Thrombectomy Device Market Revenue, By Product Type, (2016-2024) ($Mn)   
Table 64 Apac Support Devices Market Revenue, By Product Type, (2016-2024) ($Mn)   
Table 65 Apac Neurovascular Intervention Devices Market Revenue, By Application, (2016-2024) ($Mn)   
Table 66 Apac Neurovascular Intervention Devices Market Revenue, By Country, (2016-2024) ($Mn)   
Table 67 RoW Neurovascular Intervention Devices Market Revenue, By Product, (2016-2024) ($Mn)   
Table 68 RoW Artificial Embolization Device Market, By Product Type, (2016-2024) ($Mn)   
Table 69 RoW Coils Market Revenue, By Product Type, (2016-2024) ($Mn)   
Table 70 Row Stents Market Revenue, By Product Type, (2016-2024) ($Mn)   
Table 71 RoW Intracranial Stents Market Revenue, By Product Type, (2016-2024) ($Mn)   
Table 72 RoW Thrombectomy Device Market Revenue, By Product Type, (2016-2024) ($Mn)   
Table 73 RoW Support Devices Market Revenue, By Product Type, (2016-2024) ($Mn)   
Table 74 RoW Neurovascular Intervention Devices Market Revenue, By Application, (2016-2024) ($Mn)   
Table 75 RoW Neurovascular Intervention Devices Market Revenue, By Country, (2016-2024) ($Mn)   
Table 76 Agreement (2016 - 2018)   
Table 77 Approvals (2016 - 2018)   
Table 78 Acquisitions (2016 - 2018)   
Table 79 New Product Launch (2016 - 2018)   
Table 80 Other Developments (2016 - 2018)   
Table 81 Abbott Laboratories: Total Revenue And R&D Expenses,(2015-2017) ($Mn)   
Table 82 Abbott Laboratories: Total Revenue  By Segments,(2015-2017) ($Mn)   
Table 83 Abbott Laboratories: Total Revenue  By Geography, (2015-2017) ($Mn)   
Table 84 Boston Scientific Corporation: Total Revenue And R&D Expenses, (2015-2017) ($Mn)   
Table 85 Boston Scientific Corporation: Total Revenue, By Segments, (2015-2017) ($Mn)               
Table 86 Boston Scientific Corporation: Total Revenue, By Geography (2015-2017) ($Mn)   
Table 87 Cardinal Health Inc: Total Revenue And    R&D Expenses, (2015-2017) ($Mn)   
Table 88 Cardinal Health Inc: Total Revenue, By Segments, (2015-2017) ($Mn) 
Table 89 Cardinal Health Inc: Total Revenue, By Geography (2015-2017) ($Mn)   
Table 90 Inspiremd, Inc: Total Revenue And  R&D Expenses,(2015-2017) ($Mn)   
Table 91 Inspiremd: Total Revenue,  By Segments, (2015-2017) ($Mn)   
Table 92 Inspiremd, Inc: Total Revenue,  By Geography, (2015-2017) ($Mn)   
Table 93 Johnson & Johnson: Total Revenue And  R&D Expenses, (2015-2017) ($Mn)   
Table 94 Johnson & Johnson: Total Revenue, By Segments, (2015-2017) ($Mn)   
Table 95 Johnson & Johnson: Total Revenue, By Medical Devices Segments, (2015-2017) ($Mn)   
Table 96 Johnson & Johnson: Total Revenue, By Orthopaedics Segments, (2015-2017) ($Mn)   
Table 97 Johnson & Johnson: Total Revenue, By Geography, (2015-2017) ($Mn)   
Table 98 Medtronic, Plc: Total Revenue And  R&D Expenses,(2015-2017) ($Mn)   
Table 99 Medtronic, Plc: Total Revenue, By Segments, (2015-2017) ($Mn)   
Table 100 Medtronic, Plc: Restorative Therapies Group Total Revenue, By Sub-Segments, (2015-2017) ($Mn)   
Table 101 Medtronic, Plc: Total Revenue, By Geography, (2015-2017) ($Mn)   
Table 102 Microport Scientific Corporation: Total Revenue And  R&D Expenses, (2015-2017) ($Mn)   
Table 103 Microport Scientific Corporation: Total Revenue, By Segments, (2015-2017) ($Mn)   
Table 104 Microport Scientific Corporation: Total Revenue, By Geography, (2015-2017) ($Mn)   
Table 105 Penumbra, Inc: Total Revenue And  R&D Expenses, (2015-2017) ($Mn)   
Table 106 Penumbra, Inc: Total Revenue, By Segments, (2015-2017) ($Mn)   
Table 107 Penumbra, Inc: Total Revenue,  By Geography, (2015-2017) ($Mn)   
Table 108 Stryker Corporation: Total Revenue And  R&D Expenses, (2015-2017) ($Mn)   
Table 109 Stryker Corporation: Total Revenue, By Segments, (2015-2017) ($Mn)   
Table 110 Stryker Corporation: Total Revenue, By Neurotechnology And Spine Sub-Segment, (2014-2016) ($Mn)   
Table 111 Stryker Corporation: Total Revenue, By Geography, (2014-2016) ($Mn)   
Table 112 Terumo Corporation: Total Revenue And  R&D Expenses, (2015-2017) ($Mn)   
Table 113 Terumo Corporation: Total Revenue,  By Segments, (2015-2017) ($Mn)   
Table 114 Terumo Corporation Cardiac & Vascular Business: Total Revenue, By Segments, (2015-2017) ($Mn)         
Table 115 Terumo Corporation: Total Revenue, By Geography (2015-2017) ($Mn)   

List Of Figures
Figure 1 Neurovascular Intervention Devices Global Market Revenue, By Region (2016-2024) ($Mn)   
Figure 2 Research Methodology: Neurovascular Intervention Devices Global Market   
Figure 3 Neurovascular Intervention Devices Global Market: Top-Down And Bottom-Up Approach     
Figure 4 Neurovascular Intervention Devices Global Market: Forecasting Model   
Figure 5 Neurovascular Intervention Devices Global Market: Market Breakdown & Data Triangulation   
Figure 6 Neurovascular Intervention Devices Global Market Segmentation   
Figure 7 Market Dynamics   
Figure 8 Neurovascular Intervention Devices Global Market: Patent Filing By Major Players (2012–2017)   
Figure 9 Neurovascular Intervention Devices Global Market: Porter’s Analysis   
Figure 10 Neurovascular Intervention Devices Global Market: Supply Chain Analysis 
Figure 11 Neurovascular Intervention Devices Global Market Share Analysis, By Key Players, 2017 (%)   
Figure 12 Coils Global Market Share Analysis, By Key Players, 2017 (%)   
Figure 13 Flow Diverters Global Market Share Analysis, By Key Players, 2017 (%)   
Figure 14 Intracranial Stent Global Market Share Analysis, By Key Players, 2017 (%)   
Figure 15 Carotid Stent Global Market Share Analysis, By Key Players, 2017 (%)                       
Figure 16 Stent Retriever Market Share Analysis, By Key Players, 2017 (%)   
Figure 17 Coil Number Of Units, By Region (2017 V/S 2024) (No’S)   
Figure 18 Liquid Embolics Number Of Units,  By Region (2017 V/S 2024) (No’S)   
Figure 19 Stent Retreiver Number Of Units,  By Region (2017 V/S 2024) (No’S)   
Figure 20 Carotid Stent Number Of Units,  By Region (2017 V/S 2024) (No’S)   
Figure 21 Neurovascular Intervention Device U.S. Market Penetration, By Application (2017) (%)   
Figure 22 Neurovascular Intervention Devices Global Market Revenue, By Product (2017 V/S 2024) ($Mn)   
Figure 23 Artificial Embolization Devices Global Market Revenue, By Product Type (2017) ($Mn)   
Figure 24 Artificial Embolization Devices Global Market Share, By Region, (2017 V/S 2024) (%)         
Figure 25 Coils Global Market Revenue, By Product Type, (2017 V/S 2024) ($Mn)   
Figure 26 Coils Global Market Share,  By Region, (2017 V/S 2024) (%)   
Figure 27 Bare Metal Coils Global Market Share, By Region, (2017 V/S 2024) (%)
Figure 28 Coated Coils Global Market Share,  By Region, (2017 V/S 2024) (%)   
Figure 29 Liquid Embolics Global Market Share, By Region, (2017 V/S 2024) (%)   
Figure 30 Flow Diverters Global Market Share, By Region, (2017 V/S 2024) (%)   
Figure 31 Flow Disruptor Global Market Share, By Region, (2017 V/S 2024) (%)   
Figure 32 Stents Global Market Revenue, By Product Type (2017 V/S 2024) ($Mn)   
Figure 33 Stents Global Market Revenue, By Product Type (2017) ($Mn)   
Figure 34 Stents Global Market Share, By Region, (2017 V/S 2024) (%)   
Figure 35 Intracranial Stents Global Market Revenue, By Product Type (2017 V/S 2024) ($Mn)                          
Figure 36 Intracranial Stents Global Market Share, By Region, (2017 V/S 2024) (%)   
Figure 37 Stenosis Stents Global Market Share, By Region, (2017 V/S 2024) (%)   
Figure 38 Aneurysm Coil Stents Global Market Share, By Region, (2017 V/S 2024) (%)   
Figure 39 Neck Reconstruction Stents Global Market Share, By Region, (2017 V/S 2024) (%)   
Figure 40 Stent Graft Global Market Share,  By Region, (2017 V/S 2024) (%)   
Figure 41 Carotid Stents Global Market Share, By Region, (2017 V/S 2024) (%)   
Figure 42 Thrombectomy Devices Global Market Revenue, By Type (2017 V/S 2024) ($Mn)                   
Figure 43 Thrombectomy Devices Global Market Share, By Region, (2017 V/S 2024) (%)   
Figure 44 Stent Retrievers Global Market Share, By Region, (2017 V/S 2024) (%)   
Figure 45 Aspiration Devices Global Market Share, By Region, (2017 V/S 2024) (%)   
Figure 46 Support Devices Global Market Revenue, By Product Type (2017 V/S 2024) ($Mn)   
Figure 47 Support Devices Global Market Share, By Region, (2017 V/S 2024) (%)   
Figure 48 Microcatheters Global Market Share, By Region, (2017 V/S 2024) (%)   
Figure 49 Embolic Protection System Global Market Share, By Region, (2017 V/S 2024) (%)   
Figure 50 Others Global Market Share,  By Region, (2017 V/S 2024) (%)   
Figure 51 Neurovascular Intervention Devices Global Market Revenue, By Application, (2017 V/S 2024) ($Mn)   
Figure 52 Intracranial Aneurysm Global Market Share, By Region, (2017 V/S 2024) (%)   
Figure 53 Ischemic Stroke Global Market Share, By Region, (2017 V/S 2024) (%)   
Figure 54 Arteriovenous Malformation Global Market Share, By Region, (2017 V/S 2024) (%)   
Figure 55 Carotid Stenosis & Others Global Market Share, By Region, (2017 V/S 2024) (%)   
Figure 56 Neurovascular Intervention Devices Global Market Revenue, By Region, (2016-2024) ($Mn), Cagr (%)   
Figure 57 North America Neurovascular Intervention Devices Market Share, By Product & Application, (2017 V/S 2024) (%)   
Figure 58 North America Artficial Embolization Devices & Stent Market Share, By Product Type, (2017 V/S 2024) (%)   
Figure 59 North America Thrombectomy Devices & Support Devices Market Share, By Product Type, (2017 V/S 2024) (%)   
Figure 60 North America Neurovascular Intervention Devices Global Market Share, By Country, (2017 V/S 2024) (%)   
Figure 61 U.S. Neurovascular Intervention Devices Market Revenue, By Product & Application, (2017 V/S 2024) ($Mn)   
Figure 62 Others Neurovascular Intervention Devices Market Revenue, By Product & Application, (2017 V/S 2024) ($Mn)   
Figure 63 Europe Neurovascular Intervention Devices Share, By Product & Application (2017 V/S 2024) (%)   
Figure 64 Europe Artificial Embolization Device & Stent Market Share, By Product Type, (2017 V/S 2024) (%)   
Figure 65 Europe Thrombectomy Device & Support Device Market Share, By Product Type Market, (2017 V/S 2024) (%)   
Figure 66 Europe Neurovascular Intervention Devices Global Market Revenue, By Country, (2017 V/S 2024) ($Mn)   
Figure 67 Germany Neurovascular Intervention Devices Market Revenue, By Product & Application, (2017 V/S 2024) ($Mn)   
Figure 68 U.K. Neurovascular Intervention Devices Market Revenue, By Product & Application, (2017 V/S 2024) ($Mn)   
Figure 69 France Neurovascular Intervention Devices Market Revenue, By Product & Application, (2017 V/S 2024) ($Mn)   
Figure 70 Others Neurovascular Intervention Devices Market Revenue, By Product & Application, (2017 V/S 2024) ($Mn)   
Figure 71 Apac Neurovascular Intervention Devices Share, By Product & Application, (2017 V/S 2024) (%)   
Figure 72 Apac Artificial Embolization Device & Stent Market Share, By Product Type, (2017 V/S 2024) (%)   
Figure 73 Apac Thombectomy Device & Support Device Market Share, By Product Type, (2017 V/S 2024) (%)   
Figure 74 Apac Neurovascular Intervention Devices Global Market Share, By Country, (2017 V/S 2024) (%)   
Figure 75 Japan Neurovascular Intervention Devices Market Revenue, By Product & Application, (2017 V/S 2024) ($Mn)   
Figure 76 China Neurovascular Intervention Devices Market Revenue, By Product & Application, (2017 V/S 2024) ($Mn)   
Figure 77 India Neurovascular Intervention Devices Market Revenue, By Product & Application, (2017 V/S 2024) ($Mn)   
Figure 78 Others Neurovascular Intervention Devices Market Revenue, By Product & Application, (2017 V/S 2024) ($Mn)   
Figure 79 RoW Neurovascular Intervention Devices Share, By Product & Application, (2017 V/S 2024) (%)   
Figure 80 RoW Artificial Embolizaton Device & Stent Marketshare, By Product Type, (2017 V/S 2024) (%)   
Figure 81 RoW Thrombectomy Device Devices & Support Device Market Share, By Product Type, (2017 V/S 2024) (%)   
Figure 82 RoW Neurovascular Intervention Devices Global Market Share, By Country, (2017 V/S 2024) (%)   
Figure 83 Brazil Neurovascular Intervention Devices Market Revenue, By Product & Application, (2017 V/S 2024) ($Mn)   
Figure 84 Rest Of Latin America Neurovascular Intervention Devices Market Revenue, By Product & Application, (2017 V/S 2024) ($Mn)   
Figure 85 Middle East And Others Neurovascular Intervention Devices Market Revenue, By Product & Application, (2017 V/S 2024) ($Mn)   
Figure 86 Key Growth Strategies, (2016-2018)   
Figure 87 Swot: Abbott Laboratories   
Figure 88 Swot: Acandis Gmbh   
Figure 89 Swot: Balt Extrusion   
Figure 90 Swot: Boston Scientific Corporation   
Figure 91 Swot: Cardinal Health Inc   
Figure 92 Swot: Inspiremd, Inc   
Figure 93 Swot: Johnson & Johnson   
Figure 94 Swot: Medtronic, Plc   
Figure 95 Swot: Microport Scientific Corporation   
Figure 96 Swot: Penumbra, Inc   
Figure 97 Swot: Phenox Gmbh   
Figure 98 Swot: Stryker Corporation   
Figure 99 Swot: Terumo Corporation   

List Of Figures
Figure 1 Neurovascular Intervention Devices Global Market Revenue, By Region (2016-2024) ($Mn)   
Figure 2 Research Methodology: Neurovascular Intervention Devices Global Market   
Figure 3 Neurovascular Intervention Devices Global Market: Top-Down And Bottom-Up Approach     
Figure 4 Neurovascular Intervention Devices Global Market: Forecasting Model   
Figure 5 Neurovascular Intervention Devices Global Market: Market Breakdown & Data Triangulation   
Figure 6 Neurovascular Intervention Devices Global Market Segmentation   
Figure 7 Market Dynamics   
Figure 8 Neurovascular Intervention Devices Global Market: Patent Filing By Major Players (2012–2017)   
Figure 9 Neurovascular Intervention Devices Global Market: Porter’s Analysis   
Figure 10 Neurovascular Intervention Devices Global Market: Supply Chain Analysis 
Figure 11 Neurovascular Intervention Devices Global Market Share Analysis, By Key Players, 2017 (%)   
Figure 12 Coils Global Market Share Analysis, By Key Players, 2017 (%)   
Figure 13 Flow Diverters Global Market Share Analysis, By Key Players, 2017 (%)   
Figure 14 Intracranial Stent Global Market Share Analysis, By Key Players, 2017 (%)   
Figure 15 Carotid Stent Global Market Share Analysis, By Key Players, 2017 (%)                       
Figure 16 Stent Retriever Market Share Analysis, By Key Players, 2017 (%)   
Figure 17 Coil Number Of Units, By Region (2017 V/S 2024) (No’S)   
Figure 18 Liquid Embolics Number Of Units,  By Region (2017 V/S 2024) (No’S)   
Figure 19 Stent Retreiver Number Of Units,  By Region (2017 V/S 2024) (No’S)   
Figure 20 Carotid Stent Number Of Units,  By Region (2017 V/S 2024) (No’S)   
Figure 21 Neurovascular Intervention Device U.S. Market Penetration, By Application (2017) (%)   
Figure 22 Neurovascular Intervention Devices Global Market Revenue, By Product (2017 V/S 2024) ($Mn)   
Figure 23 Artificial Embolization Devices Global Market Revenue, By Product Type (2017) ($Mn)   
Figure 24 Artificial Embolization Devices Global Market Share, By Region, (2017 V/S 2024) (%)         
Figure 25 Coils Global Market Revenue, By Product Type, (2017 V/S 2024) ($Mn)   
Figure 26 Coils Global Market Share,  By Region, (2017 V/S 2024) (%)   
Figure 27 Bare Metal Coils Global Market Share, By Region, (2017 V/S 2024) (%)
Figure 28 Coated Coils Global Market Share,  By Region, (2017 V/S 2024) (%)   
Figure 29 Liquid Embolics Global Market Share, By Region, (2017 V/S 2024) (%)   
Figure 30 Flow Diverters Global Market Share, By Region, (2017 V/S 2024) (%)   
Figure 31 Flow Disruptor Global Market Share, By Region, (2017 V/S 2024) (%)   
Figure 32 Stents Global Market Revenue, By Product Type (2017 V/S 2024) ($Mn)   
Figure 33 Stents Global Market Revenue, By Product Type (2017) ($Mn)   
Figure 34 Stents Global Market Share, By Region, (2017 V/S 2024) (%)   
Figure 35 Intracranial Stents Global Market Revenue, By Product Type (2017 V/S 2024) ($Mn)                          
Figure 36 Intracranial Stents Global Market Share, By Region, (2017 V/S 2024) (%)   
Figure 37 Stenosis Stents Global Market Share, By Region, (2017 V/S 2024) (%)   
Figure 38 Aneurysm Coil Stents Global Market Share, By Region, (2017 V/S 2024) (%)   
Figure 39 Neck Reconstruction Stents Global Market Share, By Region, (2017 V/S 2024) (%)   
Figure 40 Stent Graft Global Market Share,  By Region, (2017 V/S 2024) (%)   
Figure 41 Carotid Stents Global Market Share, By Region, (2017 V/S 2024) (%)   
Figure 42 Thrombectomy Devices Global Market Revenue, By Type (2017 V/S 2024) ($Mn)                   
Figure 43 Thrombectomy Devices Global Market Share, By Region, (2017 V/S 2024) (%)   
Figure 44 Stent Retrievers Global Market Share, By Region, (2017 V/S 2024) (%)   
Figure 45 Aspiration Devices Global Market Share, By Region, (2017 V/S 2024) (%)   
Figure 46 Support Devices Global Market Revenue, By Product Type (2017 V/S 2024) ($Mn)   
Figure 47 Support Devices Global Market Share, By Region, (2017 V/S 2024) (%)   
Figure 48 Microcatheters Global Market Share, By Region, (2017 V/S 2024) (%)   
Figure 49 Embolic Protection System Global Market Share, By Region, (2017 V/S 2024) (%)   
Figure 50 Others Global Market Share,  By Region, (2017 V/S 2024) (%)   
Figure 51 Neurovascular Intervention Devices Global Market Revenue, By Application, (2017 V/S 2024) ($Mn)   
Figure 52 Intracranial Aneurysm Global Market Share, By Region, (2017 V/S 2024) (%)   
Figure 53 Ischemic Stroke Global Market Share, By Region, (2017 V/S 2024) (%)   
Figure 54 Arteriovenous Malformation Global Market Share, By Region, (2017 V/S 2024) (%)   
Figure 55 Carotid Stenosis & Others Global Market Share, By Region, (2017 V/S 2024) (%)   
Figure 56 Neurovascular Intervention Devices Global Market Revenue, By Region, (2016-2024) ($Mn), Cagr (%)   
Figure 57 North America Neurovascular Intervention Devices Market Share, By Product & Application, (2017 V/S 2024) (%)   
Figure 58 North America Artficial Embolization Devices & Stent Market Share, By Product Type, (2017 V/S 2024) (%)   
Figure 59 North America Thrombectomy Devices & Support Devices Market Share, By Product Type, (2017 V/S 2024) (%)   
Figure 60 North America Neurovascular Intervention Devices Global Market Share, By Country, (2017 V/S 2024) (%)   
Figure 61 U.S. Neurovascular Intervention Devices Market Revenue, By Product & Application, (2017 V/S 2024) ($Mn)   
Figure 62 Others Neurovascular Intervention Devices Market Revenue, By Product & Application, (2017 V/S 2024) ($Mn)   
Figure 63 Europe Neurovascular Intervention Devices Share, By Product & Application (2017 V/S 2024) (%)   
Figure 64 Europe Artificial Embolization Device & Stent Market Share, By Product Type, (2017 V/S 2024) (%)   
Figure 65 Europe Thrombectomy Device & Support Device Market Share, By Product Type Market, (2017 V/S 2024) (%)   
Figure 66 Europe Neurovascular Intervention Devices Global Market Revenue, By Country, (2017 V/S 2024) ($Mn)   
Figure 67 Germany Neurovascular Intervention Devices Market Revenue, By Product & Application, (2017 V/S 2024) ($Mn)   
Figure 68 U.K. Neurovascular Intervention Devices Market Revenue, By Product & Application, (2017 V/S 2024) ($Mn)   
Figure 69 France Neurovascular Intervention Devices Market Revenue, By Product & Application, (2017 V/S 2024) ($Mn)   
Figure 70 Others Neurovascular Intervention Devices Market Revenue, By Product & Application, (2017 V/S 2024) ($Mn)   
Figure 71 Apac Neurovascular Intervention Devices Share, By Product & Application, (2017 V/S 2024) (%)   
Figure 72 Apac Artificial Embolization Device & Stent Market Share, By Product Type, (2017 V/S 2024) (%)   
Figure 73 Apac Thombectomy Device & Support Device Market Share, By Product Type, (2017 V/S 2024) (%)   
Figure 74 Apac Neurovascular Intervention Devices Global Market Share, By Country, (2017 V/S 2024) (%)   
Figure 75 Japan Neurovascular Intervention Devices Market Revenue, By Product & Application, (2017 V/S 2024) ($Mn)   
Figure 76 China Neurovascular Intervention Devices Market Revenue, By Product & Application, (2017 V/S 2024) ($Mn)   
Figure 77 India Neurovascular Intervention Devices Market Revenue, By Product & Application, (2017 V/S 2024) ($Mn)   
Figure 78 Others Neurovascular Intervention Devices Market Revenue, By Product & Application, (2017 V/S 2024) ($Mn)   
Figure 79 RoW Neurovascular Intervention Devices Share, By Product & Application, (2017 V/S 2024) (%)   
Figure 80 RoW Artificial Embolizaton Device & Stent Marketshare, By Product Type, (2017 V/S 2024) (%)   
Figure 81 RoW Thrombectomy Device Devices & Support Device Market Share, By Product Type, (2017 V/S 2024) (%)   
Figure 82 RoW Neurovascular Intervention Devices Global Market Share, By Country, (2017 V/S 2024) (%)   
Figure 83 Brazil Neurovascular Intervention Devices Market Revenue, By Product & Application, (2017 V/S 2024) ($Mn)   
Figure 84 Rest Of Latin America Neurovascular Intervention Devices Market Revenue, By Product & Application, (2017 V/S 2024) ($Mn)   
Figure 85 Middle East And Others Neurovascular Intervention Devices Market Revenue, By Product & Application, (2017 V/S 2024) ($Mn)   
Figure 86 Key Growth Strategies, (2016-2018)   
Figure 87 Swot: Abbott Laboratories   
Figure 88 Swot: Acandis Gmbh   
Figure 89 Swot: Balt Extrusion   
Figure 90 Swot: Boston Scientific Corporation   
Figure 91 Swot: Cardinal Health Inc   
Figure 92 Swot: Inspiremd, Inc   
Figure 93 Swot: Johnson & Johnson   
Figure 94 Swot: Medtronic, Plc   
Figure 95 Swot: Microport Scientific Corporation   
Figure 96 Swot: Penumbra, Inc   
Figure 97 Swot: Phenox Gmbh   
Figure 98 Swot: Stryker Corporation   
Figure 99 Swot: Terumo Corporation

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Asahi Intecc Co., Ltd.
  • Balt Extrusion
  • Balton Sp. z o.o.
  • Boston Scientific Corporation
  • Cardiatis
  • Cardinal Health Inc
  • Contego Medical, LLC
  • Evasc Medical Systems
  • Inspire MD
  • Johnson & Johnson
  • Medtronic Plc
  • Merlin MD Pte. Ltd.
  • Microport Scientific Corporation
  • NexGen Medical Systems, Inc
  • Oxford Endovascular Ltd
  • Penumbra Inc
  • Perflow Medical Ltd
  • Phenox GmbH
  • Rapid Medical
  • Silk Road Medical Inc
  • Stryker Corporation
  • Terumo Corporation
  • W. L. Gore & Associates, Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll